Benazepril News
Cadila to market benazepril tablets in U.S.
Drug maker Cadila Healthcare Ltd said on Monday its Zydus Cadila unit received the U.S.
Higher-Dose Amlodipine Besylate/Benazepril HCl Capsules (Lotrel) for Managing Hypertension
On April 11, the FDA approved 5-mg/40-mg and 10-mg/40-mg amlodipine besylate/benazepril HCl capsules (Lotrel, made by Novartis Pharmaceuticals Corp) for use in the management of hypertension.
Polypharmacy - A Case Report and New Protocol for Management
A New Protocol for the Management of Polypharmacy
FDA Approves New Lotrel 5/40 mg and 10/40 mg Dosage Strengths
Novartis Pharmaceuticals Corporation announced it has received marketing approval from the U.S. Food and Drug Administration (FDA) for two new dosing strengths of Lotrel (R) (amlodipine besylate/benazepril HCl), 5/40 mg and 10/40...
Aldactone Added to ACE or ARB Reduces Albuminuria in Type 2 Diabetes
For type 2 diabetes with albuminuria persisting despite ACE inhibitors or angiotensin receptor blockers (ARBs), adding Aldactone (spironolactone) significantly reduced 24-hour urine albumin excretion, researchers reported here.